Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
Recruiting · NCT04741906 · Observational (researchers observe without assigning treatment) · Lead sponsor: Copenhagen University Hospital at Herlev
View the official record on ClinicalTrials.gov →Interventions studied
Dental implant surgeryProsthetic treatment
What this trial is about
Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patient with cancer or osteoporosis, treated with antiresorptive treatment.
- The patients should have sufficient compliance, this includes willingness to have the planned assessments
- The patient should have an expected life span at enrollment of at least 2 years.
- The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988.
Exclusion criteria
- \> 10 cigarettes daily
- HbA1c \> 53 mmol/mol
- Poor oral hygiene
- Poor general condition: ECOG score 3 or 4.
- Poor prognosis: Expected survival \<2 year is an exclusion cause.
- Presence of metastases of the liver brain.
- Poor local jaw bone quality acc. to Cawood classification stage 3 or 4.
- Unwillingness to comply with the planned assessments and recordings
Where it is running
1 location listed.
- Copenhagen University Hospital, Maxillofacial Department - Copenhagen, Danmark, Denmark